VTV Therapeutics Inc. Class AVTVT
13F holders, Q3 2024 (September 30)20holders +1
5new positions
4sold out
$13.53avg. 13F price*
At the end of Q3 2024, 20 institutions reported holding VTV Therapeutics Inc. Class A (VTVT) in their 13F filings, up 1 from Q2 2024. 5 opened new positions and 4 sold out. The largest holders were Samsara Biocapital, LLC ($2.8M), FMR LLC ($2.4M) and Baker Bros. Advisors LP ($1.3M).
- Company
- VTV Therapeutics Inc. Class A
- CUSIP
- 918385204
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q2 2024 → Q3 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 5 | $2.5M |
| Exits | 4 | $217K |
All 13F filers, Q2 2024 → Q3 2024: 206,105 shares bought and 15,574 shares sold, net +190,531 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 20 holders
| Samsara Biocapital, LLC | 0.54% | No change | 206,784 | $2.8M |
| FMR LLC | 0.00% | New | 178,200 | $2.4M |
| Baker Bros. Advisors LP | 0.01% | No change | 97,314 | $1.3M |
| Vanguard Group Inc. | 0.00% | Add +69.2% | 41,558 | $560K |
| Geode Capital Management, LLC | 0.00% | New | 10,307 | $139K |
| BlackRock, Inc. | 0.00% | — | 4,750 | $64K |
| UBS Group AG | 0.00% | Reduce -79.3% | 866 | $12K |
| Morgan Stanley | 0.00% | No change | 840 | $11K |
| Planning Capital Management Corp | 0.01% | No change | 625 | $8K |
| Royal Bank of Canada | 0.00% | New | 296 | $4K |
| Tower Research Capital LLC (TRC) | 0.00% | New | 269 | $4K |
| Osaic Holdings, Inc. | 0.00% | Add +4.7% | 178 | $2K |
| Strengthening Families & Communities, LLC | 0.00% | No change | 173 | $2K |
| Activest Wealth Management | 0.00% | No change | 50 | $678 |
| Parallel Advisors, LLC | 0.00% | No change | 38 | $515 |
| Planned Solutions, Inc. | 0.00% | New | 25 | $339 |
| Cornerstone Planning Group LLC | 0.00% | No change | 19 | $265 |
| Sunbelt Securities, Inc. | 0.00% | No change | 15 | $203 |
| BNP Paribas Financial Markets | 0.00% | No change | 9 | $121 |
| Bank of America Corp. | 0.00% | No change | 8 | $109 |
"% of holder's portfolio" is VTVT's weight in each manager's 13F, not the share of VTV Therapeutics Inc. Class A the manager owns.